Back to Authors

Calais-Da-Silva, Fernando

A5041391005 | I4210103180

Mayo Clinic

Instituto Português de Oncologia Francisco Gentil

Citations 1

Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2015.33.15_suppl.e16114